Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 2Terminated 2Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Cholangiocarcinoma 2Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 13Oxaliplatin 9Capecitabine 6lenvatinib 5apatinib 5Cisplatin 5tislelizumab 4Surgical Procedures, Operative 4Radiofrequency Ablation 4Neoadjuvant Therapy 4Fluorouracil 4toripalimab 3sintilimab 3Radiotherapy 3Leucovorin 3Irinotecan 3regorafenib 2pembrolizumab 2durvalumab 2camrelizumab 2Stents 2Photochemotherapy 2Immunotherapy 2Hepatectomy 2Folfox protocol 2Everolimus 2Drug Therapy 2Cholangiopancreatography, Endoscopic Retrograde 2Blood Specimen Collection 21-phenyl-3,3-dimethyltriazene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Cholangiocarcinoma × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT04840537 2021-04-12

Cholangioscopy or Conventional Techniques for Indeterminate Biliary Stenosis

Hôpital Cochin

Phase NA Unknown
150 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT00653978 2011-06-22

Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures

Changhai Hospital

Phase 3 Unknown
150 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡